Carbamazepine Tablet
Product Images NDC 55154-1396

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 55154-1396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (1859fbe5 4110 4511 Bfd2 63c190886c6f 01)

Chemical structure of carbamazepine, showing a tricyclic compound with two benzene rings fused to a seven-membered ring containing nitrogen and an amide group (CONH2) attached.*

FDA Label Image

Company Logo (1859fbe5 4110 4511 Bfd2 63c190886c6f 02)

FDA Label Image

Logo (1859fbe5 4110 4511 Bfd2 63c190886c6f 03)

FDA Label Image

Bag Label (D66759a6 978d 4387 8613 3e2b2edb9da7 00)

Label for Carbamazepine Tablets USP 200 mg oral tablets, containing 10 tablets per package. The label includes dosage information, storage instructions (20° to 25°C), pharmacist dispensing instructions with a medication guide, and warnings that the unit dose package is not child resistant and intended for institutional use. Manufactured by Torrent Pharmaceuticals Ltd., India, and distributed by Major Pharmaceuticals and Cardinal Health in the USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.